NCT01762475View on ClinicalTrials.gov

Sildenafil for Cerebrovascular Dysfunction in Chronic Traumatic Brain Injury.

PHASE2CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Traumatic Brain InjuryPost-concussive Syndrome
Interventions
DRUG

Sildenafil

Trial Locations (1)

20892

National Institute of Health, Bethesda

All Listed Sponsors
collaborator

Center for Neuroscience and Regenerative Medicine (CNRM)

FED

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

National Institutes of Health (NIH)

NIH

lead

Uniformed Services University of the Health Sciences

FED

NCT01762475 - Sildenafil for Cerebrovascular Dysfunction in Chronic Traumatic Brain Injury. | Biotech Hunter | Biotech Hunter